Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Scanoskin With Planimetry as an Objective Measure of Vitiligo.

NCT03133871 is registered in ClinicalTrials.gov with Chelsea and Westminster NHS Foundation Trust as lead sponsor.

NCT NCT03133871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03133871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Scanoskin With Planimetry as an Objective Measure of Vitiligo.
Lead sponsor
Chelsea and Westminster NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
March 1, 2017
Completion date
November 20, 2018
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo